Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03384940
Title DS-8201a in Human Epidermal Growth Factor Receptor2 (HER2)-Expressing Colorectal Cancer (DESTINY-CRC01)
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Daiichi Sankyo Co., Ltd.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ITA | GBR | ESP

Additional content available in CKB BOOST